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Context: Skeletalmusclemass (SMM) is one of themajor components of humanbody composition,
with deviations from normal values often leading to sarcopenia.
Objective:Ourmajor aimwas to conduct a genome-wide DNAmethylation study in an attempt to
identify potential genomic regions associated with SMM.
Design: This was a mixed cross-sectional and longitudinal study.
Setting: Community-based study.
Participants:A total of 1550middle-agedUnited Kingdom twins (monozygotic [MZ] and dizygotic
[DZ]), 297 of which were repeatedly measured participated in the study.
MainOutcomeMeasure:Appendicular leanmass assessedusingdual-energyX-ray absorptiometry
technology, and methylated DNA immunoprecipitation sequencing DNA methylation profiling
genome-wide were obtained from each individual.
Results: Heritability estimate of SMM, with simultaneous adjustment for covariates obtained using
variance decomposition analysis, was h2 0.809 0.050. After quality control and analysis of longi-
tudinal stability, the DNA methylation data comprised of 723 029 genomic sites, with positive corre-
lations between repeatedmeasurements (Rrepeated 0.114–0.905). Correlations betweenMZ andDZ
twinswere 0.51 and 0.38 at a genome-wide average, respectively, and clearly increasedwith Rrepeated.
Testing for DNA methylation association with SMM in 50 discordant MZ twins revealed 36 081 nom-
inally significant results, of which the top-ranked 134 signals (P  .01 and Rrepeated  0.40) were
subjected to replication in the sample of 1196 individuals. Seven SMMmethylation association signals
replicated at a false discovery rate less than 0.1, and these were located in or near genes DNAH12,
CAND1,CYP4F29P, and ZFP64, whichhavepreviously beenhighlighted inmuscle-related studies.Adjust-
ing for age, smoking, and blood cell heterogeneity did not alter significance of these associations.
Conclusion: This epigenome-wide study, testing longitudinally stable methylation sites, discovered
and replicated a number of associations between DNAmethylation at CpG loci and SMM. Four repli-
cated signals were related to genes with potential muscle functions, suggesting that the methylome
ofwhole bloodmaybe informative of SMMvariation. (J Clin EndocrinolMetab 101: 2450–2459, 2016)
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Lean body mass (LBM), in particular skeletal musclemass (SMM) is one of the 3 major components of
body composition, which also includes fat body mass and
bonemass. As for the other 2 components, SMM is highly
important for normal physiology and metabolism, and
deviations from normal values are often associated with
various pathological conditions, notably sarcopenia, par-
ticularly in women (1). Sarcopenia is as a rule defined as
age-related reduction inmusclemass andmuscle strength,
and affects women more than men with the prevalence as
high as 30% for those above 60 years old (2, 3). In the
elderly, the loss of LBM is correlated with profound phys-
ical impairment and disability with severe clinical conse-
quences, including mobility loss, osteoporosis, increased
fracture risk, dyslipidemia, insulin resistance, and in-
creased mortality (4).
Despite its clinical significance and LBM has a strong
familial component (5–8), replicated and confirmed spe-
cific genetic polymorphisms are rare and can explain only
a minor part of the muscular mass variation (9–12). To
date, no confirmed genotypes are associated with accel-
erated sarcopenia or frailty, or can explain a significant
part of the interindividual variation in SMM.
Twin studies have made a remarkable contribution to
the understanding of the molecular basis of human com-
plex traits via modern high-throughput genetic and
genomic analyses, and recently epigenetic approaches (13,
14).Therehavebeenmajor advances in epigenetics related
to carcinogenesis (15, 16), psychiatric diseases (17), rheu-
matoid arthritis (18, 19), and others.However, we are not
aware of studies exploring the epigenetics of muscular
mass variation, despite suggestions of its importance (20),
and recent work has explored age-related differential
methylation signatures in human skeletal muscle (21).
The main aim of this study was therefore to conduct a
genome-wideDNAmethylation study of a large sample of
United Kingdom twins, using methylated DNA immuno-
precipitation sequencing (MeDIP-seq) in an attempt to
identify potential genomic regions where DNA methyl-
ation levels are associated with SMM variation, with a
secondary aim to obtain good estimates of heritability.
Materials and Methods
Study sample
The data examined in the present study were from the
TwinsUK Adult Twin Registry, described in detail elsewhere
(22). The sample had been collected from the general population
through national media campaigns in the United Kingdomwith-
out ascertainment for any of individual characteristics, diseases
or traits. In the present study, 1196 individuals (119 dizygotic
[DZ] and 428monozygotic [MZ] twin pairs and 102 singletons,
56 MZ and 46 DZ twins without sibling measurements) were
included having all measurements of interest. All studied indi-
vidualswere femaleswith age rangebetween17and82years and
average 51.8  13.7 years. The mean body mass index was
25.2  4.7 kg/m2, and LBM ranged between 26.0 and 60.9 kg,
with mean LBM 39.9 5.4 kg. All participants gave written
informed consent before entering the study and the St Thomas’
Hospital research ethics committee had approved the project.
Muscle mass phenotype
All 3 major body composition components, ie, bone mineral
density, fat body mass, and LBM, were measured by using stan-
dardwhole body dual-energyX-ray absorptiometrymethod (5),
following manufacturer’s recommendations (QDR 4500W sys-
tem; Hologic, Inc). Briefly, at installation, the manufacturer’s
engineer calibrated the instrument, and thendailyquality control
(QC) scans were performed using the spine phantom. Intrascan-
ner reproducibility, expressed as a coefficient of variation from
duplicate measurements in healthy volunteers 1week apart, was
0.8%at the lumbar spine. Both twinswithin a pair were scanned
on the sameday. For the purposes of this study,we defined SMM
as the sum of LBM measurements at the 4 limbs (appendicular
lean mass), and not total LBM, which is biased by measurement
of nonmuscular soft tissue, in particular viscera.
Smoking scores
The present sample included 1100 individuals for whom the
information on smoking habits was available. Of these, in 446
individuals were smokers, which included 320 current smokers
and 126 exsmokers.
For blood cell composition, whole-blood cell (WBC) subtype
counts were obtained for 441 individuals from the replication
sample (n  1196) using fluorescence-activated cell sorting
(FACS) of peripheral blood (23). WBC subtype cell counts were
available for 4 cell types: neutrophils, eosinophils, monocytes,
and lymphocytes.
DNA extraction and MeDIP-seq
Whole-blood samples (6 mL) were collected and stored at
80°C in EDTA tubes. Genomic DNA was extracted using the
BACC3 Genomic DNA Extraction kit (Nucleon) and stored in
TE buffer at 20°C. A total of 1.5 g of genomic DNA was
fragmented to a smear of 200–500 bp with the Bioruptor NGS
System (Diagenode) and was subsequently end repaired, adeny-
lated, and adapter ligated using the Paired-End DNA Sample
Prep kit (Illumina). Methylated DNAwas immunoprecipitation
using the Magnetic Methylated DNA Immunoprecipitation kit
(Diagenode) as previously described (24). After efficiency and
sensitivity assessment by quantitative PCR,MeDIP-seq libraries
were prepared by amplification (Platinum pfx DNA Polymerase
kit; Invitrogen), purification (Agencourt Ampure Beads; Beck-
man Coulter) and validation (Agilent BioAnalyzer analysis) fol-
lowed by high-throughput sequencing (Illumina HiSeq2000)
that generated approximately 50 million, 50-bp single-end
reads.
MeDIP-seq DNA methylation quantification
After adapter and base quality trimming sequencing, reads
were mapped to hg19 using BWA v0.5.9 (25). Alignments with
low quality scores (Q 10) and duplicates were filtered, which
resulted in an average of 15 684 723uniquelymapped reads that
were subsequently extended to 350 bp to represent the average
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MeDIP fragment size. Fragments per kilobase permillion ([num-
ber of mapped, extended reads per bin]/[million uniquely
mapped reads per sample]) were quantified in bins of 500-bp
(250-bp overlap) genome-wide using MEDIPS v1.6 (26).
Design of the study and statistical analysis
The analysis of the data included the following stages and
correspondingmethods andwasbasedon3nonoverlapping sub-
samples, selected from the total available sample.
The first sample was used for identification of longitudinally
stable DNA methylation regions for downstream association
analysis. For the selection of these methylation regions, we com-
puted Pearson correlations between the all-available longitudi-
nal measurements of the methylation within the individual. The
bins displaying significant intraindividual correlationswere con-
sidered as longitudinally stable, and from now on will be called
longitudinally stable bin (lsBIN). We assumed that the lsBINs
would also show significant correlation between twins, which
could be regarded as an additional confirmation of their non-
sporadic nature. To this end, 292 individuals having sequential
measurements of methylation with the same processing batch
were selected from the entire available sample (385 individuals
having at least 2 methylation measurements each). Five of them
had 2 pairs of appropriate sequential measurements each (4 in-
dividuals had 4measurements and one 3measurements with the
same batch), the rest 2 measurements only. The measurements
were takenwith at least 3 years’ time interval (mean, 7.0; SD,1.2;
range, 3.4–10.8). For the intrapair correlation, 104 pairs ofMZ
twins (219 pair of measurements) and 63 pairs of DZ twins (129
pair of measurements) with methylation measured at the same
date andwithin the same batchwere selected from the same total
sample.
The second samplewas used for initial identification of the bins
potentially associated with SMM variation. For this aim, we se-
lected 50 of the most discordant SMM pairs of MZ twins, imple-
menting a simple formula dSMMi  (dSMMi1  dSMMi1)/
0.5(dSMMi1  dSMMi1). The 50 dSMMi were explored for the
corresponding methylation differences, dMTLi. Only lsBINs were
used in this analysis. The DXA scans and methylation were taken
with less than or equal to 12 months between both types of
assessment.
The third sample was used for validation in an extended da-
taset. At this stage, lsBINs identified abovewere examined in the
remaining sample including1196 individuals in total (see above).
We tested correlation between SMM and methylation level and
used multiple regression analysis where SMMwas considered a
dependent variable, methylation level, age, and smoking as co-
variates. In a subset of this sample (n441)with availableWBC,
we also considered WBC subtype proportions for association
with DNA methylation levels at the 7 top-ranked SMM-associ-
ated methylation signals and found no differences in the pattern
of their association.
To evaluate the contributionof the additive genetic factors (her-
itability estimates, h2) to variation and covariation of SMM and
methylation levels of the significantly associated bins, we carried
out uni- and bivariate variance decomposition analysis, based on a
classical polygenic conceptof thequantitative trait inheritance.The
analysis was conducted by MAN statistical package for family-
based samples (http://www.tau.ac.il/idak/hid_MAN.htm).
Functional genomic and CpG island (CGI)
annotations
Annotationswere obtained fromUniversity of California Santa
Cruz (UCSC) (http://hgdownload.soe.ucsc.edu/goldenPath/hg19/
database/cpgIslandExt.txt.gz). CGI shores were subsequently de-
fined as 2-kb regions up- and downstream of CGI boundaries.
Promoter (active, weak, and poised) and enhancer (strong and
weak) chromatin states predicted by ChromHMM (27) for
GM12878 (a lymphoblastoid cell line derived from blood) (28)
were also obtained from UCSC (http://hgdownload.cse.ucsc.
edu/goldenPath/hg19/encodeDCC/wgEncodeBroadHmm/
wgEncodeBroadHmmGm12878HMM.bed.gz). Distribution of
the methylation signals by the levels of their longitudinal stabil-
ity, and extent of twin correlations amongCGIs, promoters, and
enhancers was compared using standard ANOVA and t tests.
Results
Heritability of SMM
The crude SMMmeasurements showedmodest but sta-
tistically significant inverse correlation with age (r 
0.097,P .006). The intraclass correlations ofMZand
DZ twins for the age-adjusted SMM were high and sig-
nificant: RMZ 0.799, P .0001 and RDZ 0.366, P
.0008, respectively, suggestive of strong genetic influence.
Indeed the heritability estimate obtained using variance
decomposition analysis yielded h2  0.809  0.050.
Identification of longitudinally stable methylation
signals
First, from the total 11 524 145 bins quantified ge-
nome-wide, those displaying zero methylation levels in
more than 20% of the individuals were excluded, leaving
6 501 931 bins (56.4%) for further analysis (Table 1). Of
these, only a minor portion of 723 029 bins (6.3% of the
initial 11 524 145 bines) showed significant positive cor-
relation between the longitudinal MeDIP-seq measure-
ments within individuals, ranging between 0.114 and
0.905, with nominal P  .05.
Next, we computed intrapair correlations between all
6 501 931 bins, for MZ and DZ pairs separately, ie, RMZ
and RDZ. To explore whether the correlation between the
twins depends on the bin longitudinal stability, we com-
puted the correlation through all selected bins on each
chromosome between the repeated measurements
(Rrepeated) and the correlation coefficients between the
twin pairs for the corresponding bins, according to their
zygosity (RMZ and RDZ), ie, Rrepeated was contrasted with
RMZ (or RDZ).
The correlation between the RMZ and Rrepeated was at a
genome-wide average 0.51 (ranging between 0.41 and
0.58 per chromosome) and was consistently greater than
the corresponding correlation between the RDZ and
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Rrepeated, which was at a genome-wide average of 0.38
(and varied from 0.32 to 0.41 per chromosome). The cor-
responding results for each chromosome are provided in
Table 1, and exemplifying scatterplots for chromosomes
of different size are shown in Figure 1, A and B. Figure 1C
demonstrates clear significant positive correlations be-
tween the RMZ and RDZ for the corresponding bins, with
consistent tendency, RMZ  RDZ. This relationship, ex-
pressed as RMZ/RDZ (considering bins with positive and
significant RDZ), shows substantial correlation (0.46–
0.53, depending on chromosome) and highly significant
(P .0001) correlationwith Rrepeated (Figure 2). This sug-
gests that genomic regions with evidence for genetic her-
itability are more likely to be longitudinally stable.
The statistical significance (P value) of the correlations
of Rrepeated with RMZ (as well as with RDZ) per specific bin
varied widely, depending on bin and chromosome. How-
ever, when only bins with Rrepeated 0 and P .05 were
selected, all the aforementioned correlations (ie, correla-
tions between Rrepeated and RMZ, or RDZ) became highly
significant (P  108) for all chromosomes.
Identification of the methylation association with
SMM variation in MZ twins
We tested whether the lsBINs were associated with
SMM variation in the sample of 50 SMM discordant MZ
twins using paired t test to comparemethylation levels per
lsBIN.Of723 029bin comparisons, 36 081 showednom-
inally significant (P .05) association with SMM, which
corresponds closely to 5% expected from type 1 error.
These results could not be considered as entirely random,
in particular for estimating the possible rate of false pos-
itive association signals. The present analysis was con-
ducted on the small fraction of bins (6.3%), selected by
QC and longitudinal stability tests. We therefore opted
not to apply statistical correction technique to estimate the
rate of false discovery, at this stage, as this would also
increase the probability of type-2 error. Instead, of the
above lsBINs,we selectedonly those that showed inpaired
t test for discordantMZ twinsP .01 andRrepeated 0.4.
In total, 134 autosomal bins fitted the selection criteria,
and were tested in our replication sample. The distri-
bution of the P values per chromosome is shown on
Supplemental Figure 1, and the lsBINs from the most
significant t tests (P  .001) with their genomic posi-
tions are listed in Supplemental Table 1.
Replication of the association results in the
extended population sample
At this stage, correlations of the methylation levels of
the 134aforementioned autosomal lsBINswith SMM(de-
pendent variable) were examined in the remaining 1196
individuals. Results for 20 of them are presented on left
hand side of Supplemental Table 2 as unadjusted Pearson
Table 1. Summary Results of Testing for Longitudinal Stability of the Bins Methylation in 292 Individuals With 2 or
More Repeated Measurements, Taken 4 Years Apart
Chr Nini Nfiltered Nsign
Max
{Rrepeated}
Min
{Rrepeated} Nposit Corel.1 Corel.2 Corel.3
Max
{RMZ}
Max
{RDZ}
Nfiltered/
Nini
Nsign/
Nini
Nposit/
Nini
1 997 003 556 000 64 467 0.823 0.257 58 732 0.501 0.376 0.404 0.889 0.639 0.558 0.065 0.059
2 972 798 563 291 63 797 0.718 0.256 57 973 0.518 0.365 0.416 0.831 0.690 0.579 0.066 0.060
3 792 090 447 367 48 947 0.766 0.247 44 425 0.568 0.391 0.431 0.773 0.659 0.565 0.062 0.056
4 764 618 394 755 44 373 0.846 0.218 40 143 0.582 0.395 0.430 0.934 0.625 0.516 0.058 0.053
5 723 662 394 564 44 526 0.753 0.236 40 427 0.547 0.393 0.424 0.817 0.719 0.545 0.062 0.056
6 684 461 378 575 42 859 0.774 0.261 38 963 0.555 0.420 0.447 0.841 0.620 0.553 0.063 0.057
7 636 555 374 256 46 089 0.776 0.255 42 524 0.513 0.384 0.401 0.821 0.607 0.588 0.072 0.067
8 585 457 336 399 40 097 0.832 0.255 36 713 0.569 0.390 0.432 0.888 0.623 0.575 0.068 0.063
9 564 854 274 602 34 249 0.764 0.229 31 573 0.480 0.356 0.380 0.790 0.575 0.486 0.061 0.056
10 542 139 333 790 40 766 0.905 0.229 37 579 0.505 0.370 0.401 0.934 0.568 0.616 0.075 0.069
11 540 027 312 132 37 634 0.826 0.253 34 581 0.479 0.347 0.387 0.853 0.572 0.578 0.070 0.064
12 535 408 323 464 37 031 0.780 0.239 33 766 0.499 0.365 0.390 0.872 0.746 0.604 0.069 0.063
13 460 680 216 253 24 730 0.743 0.240 22 584 0.534 0.369 0.417 0.787 0.592 0.469 0.054 0.049
14 429 399 214 025 25 936 0.745 0.230 23 792 0.531 0.399 0.412 0.836 0.599 0.498 0.060 0.055
15 410 126 210 537 26 333 0.802 0.218 24 261 0.583 0.392 0.430 0.790 0.668 0.513 0.064 0.059
16 361 420 222 438 32 621 0.734 0.244 30 675 0.457 0.365 0.368 0.789 0.565 0.615 0.090 0.085
17 324 781 229 520 31 730 0.755 0.241 29 623 0.438 0.372 0.360 0.881 0.592 0.707 0.098 0.091
18 312 309 179 787 20 942 0.830 0.223 19 148 0.525 0.394 0.426 0.892 0.500 0.576 0.067 0.061
19 236 516 179 218 28 430 0.801 0.229 27 185 0.406 0.361 0.328 0.837 0.588 0.758 0.120 0.115
20 252 103 166 570 21 391 0.695 0.220 19 873 0.435 0.329 0.364 0.748 0.534 0.661 0.085 0.079
21 192 520 88 201 12 546 0.738 0.232 11 730 0.461 0.361 0.382 0.846 0.564 0.458 0.065 0.061
22 205 219 106 187 17 571 0.782 0.243 16 759 0.413 0.376 0.319 0.797 0.538 0.517 0.086 0.082
ALL 11 524 145 6 501 931 787 065 0.905 0.261 723 029 0.512 0.377 0.403 0.934 0.746 0.564 0.068 0.063
Nini, initial number of bins for chromosome; Nfiltered, number of bins after filtering: count of 0 per bin 20%; Nsign, number of bins with significant
correlation between the sequential (repeated) measurements (Rrepeated), with P  .05; Nposit, number of bins with significant and positive
correlations between the sequential measurements: P  .05 and Rrepeated  0. Correl.1 and Correl.2 are the correlations between the RRepeated and
RMZ, and RRepeated and RDZ, respectively; Correl.3 is the correlations between RMZ and RDZ. All the results are given as an average per chromosome.
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correlations, and are arranged in the descending order for
P values. The correction for multiple testing shows that 7
upper results (P values ranging between 0.0037 and
0.0003) are significant with False Discovery Rate  0.1
(marked with bold) and are given in Table 2.
We next tested whether the inclusion of the addi-
tional potential covariates, specifically age and smoking
status (available for 1100 individuals) affected the
aforementioned association results. The results are
given on the right hand side of Table 2. Their inclusion
did not change significantly the results, although age
was a consistently nominally significant covariate for
all the tested bins, whereas smoking did not show sig-
nificant effects.
Whole blood is heterogeneous collection of cells and
DNAmethylation levels may reflect cellular composition.
We therefore considered if the 7 top-ranked replicating
SMM-association signals (Table 2) were also associated
with blood cell subtypes in a subset of individuals from the
replication sample, where WBC data were available. We
observed no evidence for association at nominal signifi-
cance (P .05) between DNAmethylation levels at these
regions and the proportion of lymphocytes, neutrophils,
basophils, and eosinophils.
We explored whether these SMM methylation results
were likely caused by common genetic and/or environmen-
tal factors in SMM.We therefore conducted classical bivari-
ate variance component analysis via estimation of contribu-
tion of pleiotropic genetic factors (genetic correlation, rG)
and shared environmental effects (environmental correla-
tion, rE) and summarized in Supplemental Table 3. It pro-
vides univariate estimates of heritability (contribution of ad-
ditive genetic factors) to SMM and each of the 7 top
methylation signals, and pairwise estimates of rG and rE
between each of the bins and SMM. The heritability esti-
mates for all bins were significant and varied between
0.271  0.181 and 0.753  0.091. Interesting, by Likeli-
hood Ratio Test, genetic correlations for 5 pairs of 7 were
statistically significant, with P values from 0.0477 to
0.0002. The remaining 2 bins on chromosome 21
(15253001-15253500) and 3 (189366751-189367250),
showed nonsignificant rG and rE, when each of them were
tested separately. However, by LRT, both correlations
could not be constrained to zero (hypothesis of no correla-
Figure 1. Pairwise scatterplots of correlation coefficients between the Rrepeated, RMZ, and RDZ for the chromosomes of different size. Rrepeated,
longitudinal correlations between the repeated methylation measurements per bin. RMZ and RDZ are intrapair correlations methylation levels per
bin between the MZ and DZ twins. Columns A–C show correlation of Rrepeated with RMZ and RDZ and between RMZ and RDZ for the selected
chromosomes.
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tion is rejected), withP .0068 and 0.0293, suggesting that
statistical power of the sample is probably insufficient to
choose between rG and rE. Other findings of interest con-
cerned the environmental correlations (rE) for DNA meth-
ylation, which were all statistically nonsignificant (P values
ranged between 0.752 and 0.068), despite the fact that ini-
tially those bins were selected in the sample of discordant
MZ twins.
Distribution of methylation signals among the
CpG rich and poor genomic regions
Selected lsBINs (723 029 in total) relatively to initial
total number of bins (11 524 145) were sorted as belong-
ing to 1) CGIs, 2) CpG shores, or 3) not belonging to any
of these2 regions (CpGsea).Table3presents the summary
of these data suggesting that there is a significant loss of
lsBIN portion in CGIs (0.0017 vs 0.0032) vs clear enrich-
ment in CpG shores (0.0525 vs 0.0285).
However, when the distributions of Rrepeated in these 3
regions were compared, we found that on average signif-
icantly (P  2.221–7.616) higher values were observed
in islands (0.1857  2.4E-03) in comparison with both
CGI shores (0.1630 3.1E-04) and open seas (0.1666
8.0E-05). With respect to RMZ, there were no statistically
significant differences between the CGIs and shores, but
bothhad significantly (P3.536–1.0300) higherRMZ in
comparison with CpG seas.
Distribution of methylation signals among
functionally different genomic regions: predicted
enhancers and promoters
We conducted a comparative analysis of the distribu-
tion of lsBINs mapped to predicted enhancers and pro-
moters (Table 4, see also Supplemental Table 4). We ob-
served statistically significantly lower levels of Rrepeated in
enhancers (average Rrepeated  0.1634  0.0004, n 
53357) in comparisonwithpromoters (averageRrepeated
0.1698 0.0013, n 8412) (t7.84, P 4.715), as
expected. Within enhancers, the percentage of lsBIN de-
creases (from 8.56% to 2.29%) almost monotonically
(Spearman’s   1.0, P  .0001) with the average lon-
gitudinal stability (Rrepeated) of the bin, that is, DNAmeth-
ylation binswith strong evidence for longitudinal stability
are less likely to fall in enhancer regions compared with
DNA methylation bins with weaker evidence for longitu-
dinal stability. The relationship with promoters, exclud-
ing the last category (where Rrepeated  0.7) shows the
opposite trend (Spearman’s   0.94, P  .005), but the
trend is weaker if the last category is included. A similar
test of the lsBIN distribution in CGIs and shores reveals a
significant trend concerning the islands. In CGIs the con-
tent of lsBIN increases with their longitudinal stability,
from 0.17% at Rrepeated  0.11 to 1.83% at Rrepeated 
0.70 (by Spearman’s   0.945, P  .00048), and this
trend as expected is similar to that observed for promoter
regions.
Discussion
Webelieve this is the firstDNAmethylationstudytofocuson
SMM in a general human population. Implementing Me-
DIP-seq technology, we carried out a genome-wide associa-
tionanalysisofDNAmethylation levelswithSMMvariation
in a dataset of 1550middle-aged females. Due to the burden
of multiple testing incorporating over 10 million tests, we
restricted themethylometo themethylationsignals thatwere
minimallyprone to randomfluctuations.We thenused these
selected lsBINs in an association study with SMM in 2 in-
dependent samples, to identify robust methylation signals.
Figure 2. Dependence of RMZ to RDZ ratio on RRepeated. Rrepeated,
longitudinal correlations between the repeated methylation
measurements per bin. RMZ and RDZ are intrapair correlations
methylation levels per bin between the MZ and DZ twins.
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After QC and analysis of longitudinal stability, our
data comprised of 723 029 bins showing statistically sig-
nificant correlationsbetween repeatedmeasurementsover
time. The ratio of these correlations, RMZ to RDZ, also
increased linearly with Rrepeated, suggesting that genetic
factors determined this stability, as expected. This idea
was further confirmed in our family-based variance com-
ponent analysis of the bins most significantly associated
with SMM (Supplemental Table 3), showed heritability
estimates reaching 0.753 0.091. Thus, our data suggest
that additive genetic factors affect variation of the DNA
methylation levels of only small portion of methylation
sites in human genome and the magnitude of this effect
determines the longitudinal stability of the bins variation.
Several studies undertaken during the past decade have
estimated DNAmethylation twin heritability to variation
in DNA methylation at individual CpG sites across the
genome (eg, Refs. 29, 30). Comparing the correlations in
DNA methylation levels in blood samples between MZ
and DZ twins’ genome wide (26,690 CpG sites), Bell et al
(24) estimated mean heritability of 0.18 (95% confidence
interval, 0.168–0.185). This was confirmed by Illumina
HumanMethylation450 array on peripheral blood leuko-
cytes in a family-based sample (30). The narrow sense
methylation heritability in a genome-wide analysis of 4
brain regions showed a wide range of estimates (31). The
mean estimate of heritability for all available loci in the
latter study was only 2.8%. However, when only loci
deemed heritable were included, the mean heritability es-
timate was 29.9%, ranging from almost 0 to almost 1.0
(31).Remarkablewas the fact that thedistributionpattern
of their heritability estimates was virtually identical in
15 469 loci inCGIs and in 5531 locimapped to non-CGIs.
Interestingly, only about4%of the tested loci, in this study
(31) were considered heritable. The accurate estimate of
genome DNAmethylation depends how exactly this pro-
portion is calculated but is of the same order ofmagnitude
as that observed in our study.
As mentioned the higher the heritability estimate, the
more longitudinally stable is methylation site (Figure 2).
Furthermore, in our study the correlations between MZ
twins tended to be higher for bins located inCGIs andCGI
shores in comparison with “open sea” regions (Table 3),
whichhas not beenpreviously explored indepthdue to the
Table 2. Most Significant Correlations Between Appendicular Lean Mass and Methylation/Bin in Sample of 1196
Female Twins, and Multiple Regression Model for Appendicular Lean Mass as Dependent Variable and Methylation
(MTL), Age and Smoking Score (pSmk) as Independent Covariates
Bin
Correlation
(n  1196) Multiple Regression Model (n  1100)
Nearest Gene Name
and Locationa Gene StructureChr.
Start
Position R P _MTL P_MTL _Age P_Age _pSmk P_pSmk
3 57408751 0.1051 0.0003 0.1073 0.0004 0.0829 0.0059 0.0443 0.1404 DNAH12
57327727-530071
Intron 37 (of 58)
12 67678751 0.1022 0.0004 0.1101 0.0002 0.0858 0.0043 0.0481 0.1100 CAND1
67663061-708472
Intron 2 (of 14)
21 15253001 0.0918 0.0015 0.0981 0.0011 0.0814 0.0069 0.0392 0.1926 CYP4F29P
15215454-20685
Intergenic distance
to TSS, 32.3 kb
20 50692501 0.0917 0.0015 0.0914 0.0023 0.0853 0.0047 0.0378 0.2088 ZFP64
50700550-808524
Intergenic distance
to TSS, 8.0 kb
3 189366751 0.0874 0.0025 0.0892 0.0030 0.0845 0.0050 0.0401 0.1829 TP63
189349216-599284
Intron 1 (of 10)
22 24021751 0.0852 0.0032 0.0783 0.0095 0.0807 0.0076 0.0356 0.2384 GUSBP11
23980675-4059610
Intron 10 (of 11)
11 76513251 0.0838 0.0037 0.0798 0.0079 0.0850 0.0048 0.0411 0.1728 TSKU
76493357-509198
Intergenic (distance
to last exon,
4 kb)
Table shows the regression coefficients,  and their corresponding P values (n  1100). CALP 5 (11q13.5) belongs to the Calpain calcium-
dependent cysteine proteases involved in signal transduction in a variety of cellular processes. These endopeptidases have numerous
functions including, but not limited to, remodeling of cytoskeletal attachments to the plasma membrane during cell fusion and cell motility,
proteolytic modification of molecules in signal transduction pathways, degradation of enzymes controlling progression through the cell
cycle, regulation of gene expression. Perturbations in calpain activity have been associated in pathophysiological processes contributing to
type 2 diabetes (calpain 10), muscular dystrophy (calpain 3), and other. NRIP1 (21q21.1), nuclear receptor interacting protein 1, is a nuclear
protein that specifically interacts with the hormone-dependent activation domain AF2 of nuclear receptors. Also known as RIP140, this
protein modulates transcriptional activity of the estrogen receptor. CPM (12q15), carboxypeptidase M, the protein encoded by this gene is a
membrane-bound arginine/lysine carboxypeptidase. Its expression is associated with monocyte to macrophage differentiation. The active site
residues of carboxypeptidases A and B are conserved in this protein. It is believed to play important roles in the control of peptide hormone
and growth factor activity at the cell surface, and in the membrane-localized degradation of extracellular proteins. DNAH12 (3p14.3),
dynein, axonemal, heavy chain 12, is a protein coding gene. Force generating protein of respiratory cilia. Produces force towards the minus
ends of microtubules. Dynein has ATPase activity; the force-producing power stroke is thought to occur on release of ADP.
a Descriptions from GeneCards, http://www.genecards.org/.
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limited coverage of the Illumina 450k array. In a similar
vein, we observed trends with respect to the longitudinal
stability of methylation bins that mapped to enhancers
and promoters. The percentage of bins mapped to enha-
ncers decreased almost monotonically with increase of
Rrepeated, whereas promoters and CGIs displayed an op-
posite trend, as expected. These observations are in line
with the observed epigenetic variability and stability at
enhancers and promoters, but also suggest that longitu-
dinally stable methylation in enhancers is a rare phenom-
enon that deserves further study.
It is well established that enhancers serve as distal
regulators of gene expression. Enhancer methylation is
drastically altered in cancers and is closely related to
altered expression profiles of cancer genes (eg, Refs.
32–34), suggesting that enhancer hypo-/hypermethyl-
ation could be critical in transition from normal to ab-
errant status of the cells. Thus, it looks that the low
content of longitudinally stable methylation sites
mapped to enhancers play a protective role in transcrip-
tion regulation of the structural genes.
Our2-stage association analysis suggests that themeth-
ylation status of 5–7 regions is significantly associated
with variation of SMM. The peak 7 regions mapped pre-
dominantly within gene bodies (4 of 7) and near to the
gene transcription start site (TSS) (within 10 kb), with the
exception of the intergenic signal nearest to the CAND1
gene (32 kb to TSS). Of the 7 reported genes, the top-
ranked SMM signal was located within the DNAH12
gene, which is expressed in vastus lateralis muscle tissue
after20weeksof endurance exercise training (35). Inmice,
Zfp64 has been demonstrated to participate in regulation
of mesenchymal cell differentiation by suppression of
myogenic, andpromotionofosteoblastic, cell fate through
Notch signaling (36). Tp63has been shown tobe amarker
for skeletal muscle differentiation (37) and is also used for
Table 3. Comparison of Rrepeated and RMZ Among the 3 Genomic Regions by CpG Content
Bins Open Sea Islands Shores
Total sample 11 159 032 [0.9683] 36 957 [0.0032] 328 156 [0.0285]
n bins, study sample 683 823 (0.9458)a 1218 (0.0017)a 37 988 (0.0525)a
Rrepeated RMZ Rrepeated RMZ Rrepeated RMZ
Average 0.1666 0.2059 0.1857 0.2478 0.1630 0.2524
Variance 0.0044 0.0175 0.0068 0.0135 0.0036
0.0141
Comparison
Open Sea vs Islands Shores vs Islands Open Sea vs Shores
Rrepeated RMZ Rrepeated RMZ Rrepeated RMZ
t testb 8.06 12.56 9.50 1.35# 11.32 73.88
P value 7.6E-16 3.5E-36 2.2E-21 1.8E-01 1.1E-29 1.0E-300
Rrepeated, longitudinal correlations between the repeated methylation measurements per bin. RMZ and RDZ are intrapair correlations methylation
levels per bin between the MZ and DZ twins.
a Pairwise comparison of the specific proportions of bins at each of the genomic regions by Z-test, or implementing 2 test to compare
the distributions of bins between the sets in all cases gave statistically highly significant results, P  .001 (eg, 2  14 042, df  2,
P  106).
b P values associated with t tests were all (but 1, marked by #) statistically significant at P  .001.
Table 4. Distribution of lsBIN Mapped Functionally Different Genomic Regions
Filtering
n
Bins
Gene Function-Related Regions CpG Content-Related Regions
n Within
Enhancers
n Within
Promoters
% in
Enhancers
% in
Promoters
n Within
Shores
n Within
Islands
% Within
Shores
% Within
Islands
No filtering 11 524 145 830 367 267 412 7.21% 2.32% 328 156 36 957 2.85% 0.32%
R  0.11 723 029 61 910 16 965 8.56% 2.35% 37 988 1218 5.25% 0.17%
R  0.2 123 984 9715 2965 7.84% 2.39% 5667 353 4.57% 0.28%
R  0.3 35 205 2587 834 7.35% 2.37% 1325 100 3.76% 0.28%
R  0.4 12 224 890 311 7.28% 2.54% 479 34 3.92% 0.28%
R  0.5 4020 277 113 6.89% 2.81% 177 17 4.40% 0.42%
R  0.6 1085 73 36 6.73% 3.32% 61 6 5.62% 0.55%
R  0.7 218 5 4 2.29% 1.83% 9 4 4.13% 1.83%
The data provided genome wide and according to filtering conditions, Rrepeated. Spearman  between Rrepeated and percentage of bins mapped to
enhancers, 1.00 (P  .001), and percentage of bins. Mapped to CGIs, 0.964 (P  .0005).
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defining subsets of muscle-invasive bladder cancers (38).
Finally,GUSBP11hasbeen listed in theC480FANTOM5
coexpression cluster with numerous muscle-related top-
ranked ontology terms such as skeletal muscle, contractile
cell, myoblasts, striated muscle tissue, myotome, etc (39).
Hence, although the current study was conducted using
whole blood, 4of the 7 reported genes hadpreviously been
recognized in muscle-related studies, suggesting that the
methylome of whole blood is informative of SMM
variation.
Currently, as far as we aware, no SNPs association at
genome-wide association study (GWAS) significant level
(P  5 	 108) have been reported. Nevertheless, of the
several recent studies, one by Guo et al (40) provides ev-
idence of significant association of 3 SNPs (rs2507838,
rs7116722, and rs11826261) in/near glycine-N-acyl-
transferase (GLYAT) gene in Chinese and in Caucasian
populations. However, this gene is mapped, too far away
(2000 kb) to consider as a reliable candidate. Thus,
clearly additional GWAS and EWAS (epigenome-wide as-
sociation study) are needed to understand sarcopenia.
There are certain limitations in the present study. The
main potential bias concerns the usage of blood. Whole
blood includes a heterogeneous group of cells whose com-
position can change substantially in response to a variety
of intrinsic and environmental factors, eg, infection. We
assessed the association between DNAmethylation levels
at the7SMM-associatedand replicatedDNAmethylation
loci with blood cell counts available for the proportion of
lymphocytes, neutrophils, basophils, and eosinophils in a
subset. We found no evidence that variability in WBC
subtypeshas amajor effect onour top-rankedmusclemass
related signals. The fact that wewere also able to replicate
these association results in a large independent samplewas
reassuring, and suggests that whole blood may be infor-
mative of SMM variation. MeDIP-seq provides a cost-
effective approach to exploring broad methylation pat-
terns over the genome, but the resolution of the signal is
not at single base pair level CpG sites. This is an additional
major limitation in interpreting the methylation signals,
and requires a follow up of the identified signals at greater
resolution in future studies. Additional limitations include
using a female population only, because males were not
examined. However, using only females, could have pos-
sible advantages This approach is not prone to potential
sex differences in endocrinemilieu, especially sex steroids,
lifestyle factors, etc, and their interactions with genotype
and epigenotype, which tend to be the rule rather than the
exception (41, 42). Physical activity level, other lifestyle
factors, medications and other environmental factors
were not taken into account in this study, and may have
affected the magnitude of the estimated effects. Finally,
there are also some limitations related to the power of the
analysis. To achieve EWAS significance accounting for
multiple testing atmillions ofDNAmethylationCpG sites
would require very large sample sizes or very large effects,
which have not been observed to date. To this end our
association analysis was based only the longitudinally sta-
ble andmost robust fraction of themethylome (6.5%of
the initial methylome).
Conclusions
This large EWAS study confirmed amajor involvement of
the genetic factors (heritability) to variation of SMM in a
normal human population, and suggested that methyl-
ation levels of some genomic regions could underlie this
variation. Four of our 7 muscle mass associated methyl-
ation signals were in or near genes previously linked to
muscle, and in particular the top-ranked DNAH12 gene.
Our approach based on a selection of the lsBINs reduces
substantially the multiple testing problem and proved to
be effective in identification of the methylation sites po-
tentially affecting SMM variation.
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